EXHIBIT BRegistration Rights Agreement • May 28th, 2008 • China Pharma Holdings, Inc. • Pharmaceutical preparations • New York
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of May __, 2008, among China Pharma Holdings, Inc., a Delaware corporation (collectively with its predecessors, the "Company"), and the...Securities Purchase Agreement • May 28th, 2008 • China Pharma Holdings, Inc. • Pharmaceutical preparations • New York
Exhibit 99.1 China Pharma Holdings, Inc. Enters Into Private Placement Agreements to Raise $10 Million HAIKOU CITY, Hainan Province, China, May 28 2008 -- China Pharma Holdings, Inc. ("China Pharma" or "Company") (OTC BB: CPHI - News) which develops,...Securities Purchase Agreement • May 28th, 2008 • China Pharma Holdings, Inc. • Pharmaceutical preparations
HAIKOU CITY, Hainan Province, China, May 28 2008 -- China Pharma Holdings, Inc. ("China Pharma" or "Company") (OTC BB: CPHI - News) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced that it has entered into a Securities Purchase Agreement and a Registration Rights Agreement with institutional and accredited investors ("Investors") pursuant to which China Pharma shall issue and sell five million shares of the Company's common stock at a purchase price of $2.00 per share. The Investors shall also receive three-year warrants to purchase an aggregate of 1.25 million shares of the Company's common stock at an exercise price of $2.80 per share, subject to adjustment.
